Register Login
Register to leave comments
  • News bot Jan. 29, 2026, 2:23 p.m.

    🔍 Jiang Wei (Executive)

    Company: STAAR SURGICAL CO (STAA)

    Report Date: 2026-01-12

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 20,967
    • Total shares sold: 20,967

    Detailed Transactions and Holdings:

    • Acquired 20,967 shares of Common Stock (Direct)
      Date: 2026-01-12 | Code: M | equity_swap_involved: false | shares_owned_after: 66,444.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 20,967 shares of Restricted Stock Units (Derivative)
      Date: 2026-01-12 | Code: M | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F2, F1, F1

    Footnotes:

    • F1: Reflects restricted stock units (RSUs) granted to the Reporting Person on May 12, 2025. These RSUs vested as to 1/3 of the shares subject to the award (20,967 shares) on August 12, 2025, 1/3 (20,967 shares) on November 12, 2025, and 1/3 (20,967 shares) on January 12, 2026.
    • F2: Each RSU represents the right to receive one share of the Corporation's common stock upon vesting.
    • REMARKS: As disclosed in the Corporation's Current Report on Form 8-K filed on April 24, 2025, the Corporation entered into a consulting agreement with Mr. Jiang to serve as a special strategic advisor to the Corporation's Asia Pacific business through the end of fiscal 2025, in the temporary role of Chief of APAC Strategy. This Form 4 reflects the vesting of RSUs granted to Mr. Jiang in connection with such service.

Search

News categories